Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies

Metastatic Donor-derived Malignancies Following Simultaneous Pancreas-kidney Transplant: Three Case Reports and Management Strategies

Background. Stopping immunosuppression in a transplant patient with donor-derived malignancy offers the theoretical benefit that reconstitution of the patient’s immune system will allow “rejection” of the malignancy, as the malignancy also originates from allogeneic tissue. However, this option exis...

Full description

Bibliographic Details
Main Authors: Dominic Amara, BA, Steven A. Wisel, MD, Hillary J. Braun, MD, Eric A. Collisson, MD, Terence Friedlander, MD, Giulia Worner, NP, Garret R. Roll, MD, Ryutaro Hirose, MD, Peter G. Stock, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2021-01-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001090

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001090

Similar Items